BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

935 related articles for article (PubMed ID: 19323528)

  • 1. Stability of acylcarnitines and free carnitine in dried blood samples: implications for retrospective diagnosis of inborn errors of metabolism and neonatal screening for carnitine transporter deficiency.
    Fingerhut R; Ensenauer R; Röschinger W; Arnecke R; Olgemöller B; Roscher AA
    Anal Chem; 2009 May; 81(9):3571-5. PubMed ID: 19323528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences between acylcarnitine profiles in plasma and bloodspots.
    de Sain-van der Velden MG; Diekman EF; Jans JJ; van der Ham M; Prinsen BH; Visser G; Verhoeven-Duif NM
    Mol Genet Metab; 2013; 110(1-2):116-21. PubMed ID: 23639448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precursor ion scan profiles of acylcarnitines by atmospheric pressure thermal desorption chemical ionization tandem mass spectrometry.
    Paglia G; D'Apolito O; Corso G
    Rapid Commun Mass Spectrom; 2008 Dec; 22(23):3809-15. PubMed ID: 18980266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Newborn screening of inborn errors of metabolism by capillary electrophoresis-electrospray ionization-mass spectrometry: a second-tier method with improved specificity and sensitivity.
    Chalcraft KR; Britz-McKibbin P
    Anal Chem; 2009 Jan; 81(1):307-14. PubMed ID: 19117458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry.
    Wilcken B; Wiley V; Sim KG; Carpenter K
    J Pediatr; 2001 Apr; 138(4):581-4. PubMed ID: 11295726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term stability of amino acids and acylcarnitines in the dried blood spots used to screen newborns for metabolic disorders.
    Golbahar J; Altayab DD; Carreon E
    J Med Screen; 2014 Mar; 21(1):5-9. PubMed ID: 24531510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved MS/MS analysis of succinylacetone extracted from dried blood spots when combined with amino acids and acylcarnitine butyl esters.
    Chace DH; Lim T; Hansen CR; De Jesus VR; Hannon WH
    Clin Chim Acta; 2009 Sep; 407(1-2):6-9. PubMed ID: 19545553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous quantification of acylcarnitine isomers containing dicarboxylic acylcarnitines in human serum and urine by high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Maeda Y; Ito T; Suzuki A; Kurono Y; Ueta A; Yokoi K; Sumi S; Togari H; Sugiyama N
    Rapid Commun Mass Spectrom; 2007; 21(5):799-806. PubMed ID: 17279485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extraction and analysis of carnitine and acylcarnitines by electrospray ionization tandem mass spectrometry directly from dried blood and plasma spots using a novel autosampler.
    Thompson JW; Zhang H; Smith P; Hillman S; Moseley MA; Millington DS
    Rapid Commun Mass Spectrom; 2012 Nov; 26(21):2548-54. PubMed ID: 23008072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid UPLC-MS/MS method for simultaneous separation of 48 acylcarnitines in dried blood spots and plasma useful as a second-tier test for expanded newborn screening.
    Gucciardi A; Pirillo P; Di Gangi IM; Naturale M; Giordano G
    Anal Bioanal Chem; 2012 Aug; 404(3):741-51. PubMed ID: 22766757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development, validation and application of tandem mass spectrometry for screening of inborn metabolic disorders in Kuwaiti infants.
    Abdel-Hamid M; Tisocki K; Sharaf L; Ramadan D
    Med Princ Pract; 2007; 16(3):215-21. PubMed ID: 17409757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deuterated palmitate-driven acylcarnitine formation by whole-blood samples for a rapid diagnostic exploration of mitochondrial fatty acid oxidation disorders.
    Dessein AF; Fontaine M; Dobbelaere D; Mention-Mulliez K; Martin-Ponthieu A; Briand G; Vamecq J
    Clin Chim Acta; 2009 Aug; 406(1-2):23-6. PubMed ID: 19422814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of amino acids and acylcarnitines assay methods used in newborn screening assays by tandem mass spectrometry.
    De Jesús VR; Chace DH; Lim TH; Mei JV; Hannon WH
    Clin Chim Acta; 2010 May; 411(9-10):684-9. PubMed ID: 20122909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of hematocrit and localisation of punch in dried blood spots on levels of amino acids and acylcarnitines measured by tandem mass spectrometry.
    Holub M; Tuschl K; Ratschmann R; Strnadová KA; Mühl A; Heinze G; Sperl W; Bodamer OA
    Clin Chim Acta; 2006 Nov; 373(1-2):27-31. PubMed ID: 16797519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postnatal changes in neonatal acylcarnitine profile.
    Meyburg J; Schulze A; Kohlmueller D; Linderkamp O; Mayatepek E
    Pediatr Res; 2001 Jan; 49(1):125-9. PubMed ID: 11134502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carnitine deficiency disorders in children.
    Stanley CA
    Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acylcarnitine profiles of preterm infants over the first four weeks of life.
    Meyburg J; Schulze A; Kohlmueller D; Pöschl J; Linderkamp O; Hoffmann GF; Mayatepek E
    Pediatr Res; 2002 Nov; 52(5):720-3. PubMed ID: 12409519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application of tandem mass spectrometry on the diagnosis of fatty acid oxidation disorders].
    Han LS; Ye J; Qiu WJ; Gao XL; Wang Y; Zhang YJ; Gu XF
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):692-5. PubMed ID: 18067086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal diagnosis for organic acid disorders using two mass spectrometric methods, gas chromatography mass spectrometry and tandem mass spectrometry.
    Hasegawa Y; Iga M; Kimura M; Shigematsu Y; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Aug; 823(1):13-7. PubMed ID: 15908288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bile acylcarnitine profiles in pediatric liver disease do not interfere with the diagnosis of long-chain fatty acid oxidation defects.
    Fuda F; Narayan SB; Squires RH; Bennett MJ
    Clin Chim Acta; 2006 May; 367(1-2):185-8. PubMed ID: 16414039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.